Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame
Primary	Change in SCr value from baseline to end of treatment	16 days
Secondary	Incidence of adverse events and its severity	Up to 84 days
Secondary	Laboratory test values	Up to 84 days
Secondary	Vital signs	16 days
Secondary	ECG	Day 1,4,7,10,13,16
Secondary	The percentage of patients with Hepatorenal syndrome reversal (SCr value <=1.5 mg/dL)	16 days
Secondary	The percentage of patients showing 20% or more reduction in SCr value from the baseline	16 days
Secondary	24h Ccr, urine volume, urea nitrogen (BUN), urinary sodium excretions	16 days
Secondary	Mean arterial blood pressure, serum Na, serum K, plasma renin activity, aldosterone, norepinephrine, antidiuretic hormone (ADH), atrial natriuresis peptide (ANP)	16 days
Secondary	Overall survival	Up to 84 days
Secondary	Pharmacokinetics - assessment of blood concentration	Blood PK sample collection: pre-dose, 5, 15, 30, 60, 90, 120, 150, 180, 240, and 360 minutes post-dose

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01373606/registered